publication venue for
- Gastric cancer: The gastric microbiota - bacterial diversity and implications.. 14. 2017
- New potent HBV replication inhibitors for the management of chronic hepatitis B are needed. 2025
- Pleasurable and problematic receptive anal intercourse and diseases of the colon, rectum and anus. 2024
- Group 3 innate lymphoid cells in intestinal health and disease. 2024
- Mycobiota-host immune interactions in IBD: coming out of the shadows. 2022
- Optimizing immunotherapy for colorectal cancer. 2022
- The joys and challenges of being a physician-scientist. 2021
- Therapeutic pipeline in nonalcoholic steatohepatitis. 2021
- Immunotherapy in colorectal cancer: rationale, challenges and potential. 2019
- Hepatitis E virus: advances and challenges. 2017
- The past 10 years of gastroenterology and hepatology-reflections and predictions. 2014
- Overlap of functional dyspepsia and GERD--diagnostic and treatment implications. 2013
- Biliary tract: Is there a role for neoadjuvant and adjuvant therapy in biliary cancer? 2012
- The role of the gut microbiota in nonalcoholic fatty liver disease. 2010
- IBS: An epigenetic perspective. 2010
- Anastomoses of the lower gastrointestinal tract. 2009